BioAgilytix Labs, LLC, a leading global contract research organization focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, continues to grow its footprint both organically and through acquisitions. Jim Datin, their President and CEO, explains why the recent addition of MicroConstants and Australia-based 360biolabsĀ® to its family of companies fits in with their mission to serve as a one-stop bioanalysis partner to customers worldwide

[EPISODE 24] Dr. David Berkowitz Talks Enzymes, Radiation, And The Lincoln Marathon
On this episode of Molecular Moments, Chad Briscoe speaks with Dr. David Berkowitz, Director of the Division of Chemistry at